Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Shifted, And What Is the Outlook Through 2034?
In the last few years, there has been explosive growth in the market size of minimally invasive glaucoma surgery (MIGS) devices. The market is projected to expand from $0.7 billion in 2024 to $0.9 billion in 2025, with a compound annual growth rate (CAGR) of 28.3%. The elevation in market growth during the past period is a result of heightened awareness towards preventing blindness, bolstered investments in health care infrastructure, improved patient cognizance on sophisticated vision correction treatments, and an uptick in government initiatives.
How Much Will the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Be Worth in 2029?
The market size for minimally invasive glaucoma surgery (MIGS) devices is predicted to experience significant expansion in the coming years. It’s expected to reach $2.42 billion in 2029, with a compound annual growth rate (CAGR) of 28.1%. Factors such as the increasing incidents of eye diseases like glaucoma, an aging population, improvements in healthcare facilities, and a rising demand for safer and more effective treatments are anticipated to contribute to the growth during the forecast period. The forecast period is also likely to witness trends such as the adoption of MIGS devices, technological advancements, introduction of innovative minimally invasive glaucoma surgery devices, development of advanced implantable devices, and progress in ophthalmic technology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp
Which is the Largest Company in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc., MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.
What Are the Main Market Drivers in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Industry?
The escalating incidence of conditions impacting the eyes and vision is anticipated to stimulate the expansion of the minimally invasive glaucoma surgery (MIGS) devices sector. Lifestyle shifts, environmental factors, and aging societies are contributing to a rise in eye disorders. Tools such as minimally invasive glaucoma surgery (MIGS) devices are being innovatively employed to manage different eye illnesses, mainly concentrating on lessening the intraocular pressure (IOP) to restrict or manage the advancement of glaucoma. The National Eye Institute, a U.S. government agency, predicts that approximately 2.2 million Americans will be either entirely or partially sightless by 2030, hence implying a continuing growth driver for the minimally invasive glaucoma surgery (MIGS) devices segment due to the growing occurrences of eye disorders.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp
How Is the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segments Structured?
The minimally invasive glaucoma surgery (MIGS) devices market covered in this report is segmented –
1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products
2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma
3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets
4) By Distribution Channel: Direct Tender, Retail Sales
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users
Subsegments:
1) By Valves: Micro Shunt Valves, Non-penetrating Valves
2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants
3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt
4) By Stents: Ab-Interno Stents, Ab-Externo Stents
5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices
What Strategic Trends Are Transforming the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Leading firms in the minimally invasive glaucoma surgery (MIGS) devices market are concentrating on creating innovative products like stent injectable systems to fulfill the gaps in glaucoma management and enhance patient results. A stent injectable system, a MIGS device, implants a small stent into the body utilizing an injection-based process, typically employing a unique delivery method widely used in less invasive operations for treating conditions such as narrowed or blocked blood vessels. For example, Glaukos Corporation, an ophthalmic medical technology firm based in the United States, was granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) in August 2022 for their iStent Infinite Trabecular Micro-Bypass System. The iStent Infinite introduces a new three-stent injectable system aimed to offer constant, round-the-clock intraocular pressure (IOP) control for patients with primary open-angle glaucoma (POAG) whose IOP is not managed by previous medication or surgical treatment.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15863
This Report Delivers Insight On:
1. How big is the minimally invasive glaucoma surgery (migs) devices market, and how is it changing globally?
2. Who are the major companies in the minimally invasive glaucoma surgery (migs) devices market, and how are they performing?
3. What are the key opportunities and risks in the minimally invasive glaucoma surgery (migs) devices market right now?
4. Which products or customer segments are growing the most in the minimally invasive glaucoma surgery (migs) devices market?
5. What factors are helping or slowing down the growth of the minimally invasive glaucoma surgery (migs) devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
